Elevance Health Announces John Gallina to Retire as CFO
08 Agosto 2023 - 7:45AM
Business Wire
Mark Kaye named Executive Vice President, Chief
Financial Officer
Elevance Health (NYSE: ELV) announced today that John Gallina
will retire from his role as executive vice president and CFO later
this year. Mark Kaye has been named executive vice president and
CFO and will serve as a member of the company’s executive
leadership team, reporting directly to Gail K. Boudreaux, President
and CEO. Kaye will serve as CFO Designate from September 6 to
November 1, 2023, when he will assume full responsibility for the
role. Gallina will remain with Elevance Health serving as Special
Advisor to the CEO following his retirement as CFO to ensure a
seamless transition.
Gallina’s distinguished career in the finance and healthcare
fields spans more than four decades with nearly 30 of those years
at Elevance Health where he was appointed as CFO in 2016 leading
all financial and actuarial functions for the company including
procurement and corporate real estate. Prior to his role as CFO,
Gallina served in several leadership roles at the company including
Senior Vice President and Chief Financial Officer for the
Commercial and Specialty Business Division; Senior Vice President,
Chief Accounting Officer, and Chief Risk Officer; Senior Vice
President, Internal Audit and Continuous Improvement; and Chief
Financial Officer of Comprehensive Health Services.
“On behalf of the entire Elevance Health team, I want to thank
John for his contributions to our company over the last three
decades. John has been a valued member of our organization who has
successfully led our finance organization, navigated an
ever-changing and dynamic healthcare landscape, and played an
important role in our transformation to become a lifetime trusted
health partner,” said Gail K. Boudreaux, President and CEO. “John’s
commitment to improve the health of the people and communities we
serve is a testament to his career at Elevance Health and the
driving force behind his dedication to guide the company through
its cultural transformation,” added Boudreaux.
Kaye joins Elevance Health from Moody’s Corporation, where he
served as Chief Financial Officer with responsibility for all
global finance activities. Kaye is a seasoned C-Suite executive
with deep financial, actuarial, and business experience known for
both his leadership and passion in creating and instilling a
culture of excellence, and his commitment to long-term
sustainability and inclusion. Before joining Moody’s in 2018, Kaye
held a variety of leadership roles in strategic finance, financial
planning and analysis, and large-scale project management,
including at MassMutual Life Insurance Company and Voya
Financial.
“Mark is a well-respected leader with an extensive global
finance background, who has significant experience in leveraging
data-driven financial insight to support the execution of superior
operational and strategic decisions, including growing and scaling
businesses to drive success,” said Boudreaux. “With an innovative
and customer first mindset coupled with his passion for fostering a
high- performance culture, Mark will be a tremendous asset as we
work to deliver on our purpose to improve the health of humanity.
I’m pleased to welcome Mark to the Elevance Health team.”
Kaye holds an MBA in Finance and a BSE in Statistics and
Actuarial Science from The Wharton School of Business and the
University of Pennsylvania and is a Fellow of the Society of
Actuaries.
About Elevance Health, Inc.
Elevance Health is a lifetime, trusted health partner fueled by
its purpose to improve the health of humanity. The company supports
consumers, families, and communities across the entire care journey
– connecting them to the care, support, and resources they need to
lead healthier lives. Elevance Health’s companies serve
approximately 118 million people through a diverse portfolio of
industry-leading medical, digital, pharmacy, behavioral, clinical,
and complex care solutions. For more information, please visit
www.elevancehealth.com or follow us @ElevanceHealth on Twitter and
Elevance Health on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230807319229/en/
Investor Relations: Stephen Tanal
Stephen.Tanal@elevancehealth.com
Media Relations: Leslie Porras
Leslie.Porras@elevancehealth.com
Elevance Health (NYSE:ELV)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Elevance Health (NYSE:ELV)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024